Tarsus Pharmaceuticals Inc. (TARS) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tarsus Pharmaceuticals In...

    NASDAQ: TARS · Real-Time Price · USD
    65.17
    6.40 (10.89%)
    At close: Oct 03, 2025, 3:59 PM
    65.27
    0.15%
    After-hours: Oct 03, 2025, 07:32 PM EDT

    Tarsus Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -18.02 -4.38 -5.81 -33.45
    PEG Ratio
    		 0.54 -0.05 -0.02 0.68
    PS Ratio
    		 11.38 34.10 13.98 8.11
    PB Ratio
    		 9.27 3.02 1.87 2.77
    P/FCF Ratio
    		 -24.61 -4.84 -7.29 146.26
    P/OCF Ratio
    		 -25.08 -5.06 -7.36 123.39
    OCF/S Ratio
    		 -0.45 -6.73 -1.9 0.07
    Debt / Equity Ratio
    		 0.32 0.16 0.10 0.01
    Quick Ratio
    		 4.39 6.85 14.30 15.33
    Current Ratio
    		 4.42 6.93 14.61 15.33
    Asset Turnover
    		 0.49 0.07 0.11 0.32
    Interest Coverage
    		 -15.36 -42.78 -28.52 n/a
    Return on Equity
    		 -0.51 -0.69 -0.32 -0.08
    Return on Assets
    		 -0.31 -0.51 -0.27 -0.08
    Return on Invested Capital
    		 -0.41 -0.63 -0.29 -0.07
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.93 0.91 0.96 0.96
    Net Profit Margin
    		 -0.63 -7.79 -2.41 -0.24
    Pretax Profit Margin
    		 -0.63 -7.79 -2.41 -0.24
    Operating Profit Margin
    		 -0.66 -8.21 -2.43 -0.21
    FCF Margin
    		 -0.46 -7.05 -1.92 0.06
    EBITDA Margin
    		 -0.58 -7.55 -2.29 -0.23

    Add to Watchlist